Equities Leadership Summit 2018 Preview: Surviving and Thriving in Today's Market

Equities Editors Desk | |

Equities Leaders Summit 2018 is set to kick off this week on Dec. 5, 2018 in Miami, Florida.

Level Headed at World Crypto Con - Jenn Nash, CEO

Jack Brewer | |

Level Headed with Jack Brewer at World Crypto Con - Jenn Nash, CEO

Self-Regulation: Will it Solve Japan’s Crypto Exchange Hacking Problem?

David Drake | |

The Japan Virtual Currency Exchange Association (JVCEA),is tasked to oversee the cryptocurrency sector in Japan.

The Top 8 Investment Apps in 2018

Amy Mathews | |

Learn more about the latest investment app in 2018.

Level Headed at World Crypto Con - Steve Beauregard

Jack Brewer | | CRO Steve Beauregard joins Jack Brewer at World Crypto Con.

Examining the Cynicism Concerning the Crypto Crash of 2018: Are Markets Discounting Fundamentals?

Jason Hamlin | |

There has been mayhem in the crypto markets.

Can Blockchain Drive Growth In The Transportation Industry?

Ron Corker | |

Today, industrial insiders are describing the effect of cryptocurrency’s underlying technology, blockchain, as a force that’s positioned to promote a “tectonic shift” across many industries.

​360 Blockchain is Giving Investors an Early Entry into Potentially Disruptive Technology

Stephen L Kanaval | |

360 Blockchain Inc. BKLLF invests exclusively in innovative and practical blockchain innovations to give shareholders an opportunity at early-stage value in disruptive technologies.

Women Are Looking to Shake Up the Crypto Market

Julia Novakovich | |

Women are working hard to equalize the gender gap in cryptocurrency. This is how they’re doing it.

Europe Leads US, Asia in ICO Fundraising, What is Driving This Surge?

David Drake | |

The absence of clear regulations for the cryptocurrency industry hinders the growth for ICOs in Asia and the US. But in Europe, its crypto-friendly regulations give way to increased ICO funding.

Emerging Growth

IMV Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.


Truth on Trial: Implications for Communicators – Part III

Truth on Trial” is just one of a series of forums put on by the Schar School of Policy & Government, whose panelists are among the most influential legal, communications,…

Learn more